Valneva Announces Positive Phase 3 Pivotal Results for its Single-Shot Chikungunya Vaccine Candidate

NEXT STORY
iOnctura Strengthens Management With Appointment of Sean A. MacDonald as Chief Business Officer
PREV STORY
Passage Bio Mourns the Sudden Passing of Chairman of the Board Tadataka Yamada, M.D.
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ritter Pharmaceuticals Announces Phase 3 Plans after its End of Phase 2 Meeting with FDA on RP-G28 for Lactose Intolerance

LOS ANGELES, CA--(Marketwired - Aug 18, 2017) - Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (the ...

author_avatar
NASDAQ Market News

Progenics Pharmaceuticals Announces Collaboration with Veterans Affairs on the AI Research Program for Medical Image Analysis

author_avatar
NASDAQ Market News

Evelo Biosciences Announces Dosing of First Patient in Phase 1/2 Clinical Trial of EDP1503 in Combination with KEYTRUDA® (pembrolizumab) in Multiple Oncology Indications

-- Initial Clinical Data Expected in First Half of 2020 --CAMBRIDGE, Mass., Jan. 04, ...

author_avatar
NASDAQ Market News